NMPA Seeks Public Feedback on Export Drug Manufacturing Rules
An In – Depth Look at the New Draft Proposal for the Administration and Management...
NMPA
NMPA Implements Regulatory Reforms for Drug and Medical Device Industries
The National Medical Products Administration (NMPA) has released a notification regarding the implementation of the...
NMPA Releases 89th Batch of Reference Drugs for GQCE Work
The National Medical Products Administration (NMPA) has released the 89th batch of reference drugs for...
NMPA Releases 88th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 88th batch of reference drugs for...
NMPA Releases 87th Batch of Reference Drugs for Generic Quality Consistency
The National Medical Products Administration (NMPA) has released the 87th batch of reference drugs for...
NMPA Proposes Draft for Simplified Registration of Traditional Chinese Medicines from Hong Kong and Macao
The National Medical Products Administration (NMPA) has issued the “Notification on Simplifying the Registration and...
NMPA Releases 85th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 85th batch of reference drugs for...
China’s NHC Launches Pilot Plan to Expand Wholly Foreign-Owned Hospital Sector
The National Health Commission (NHC) has released the “Pilot Work Plan for Expanding the Wholly...
NMPA Drafts Medical Representative Management Measures, Seeks Public Input
The National Medical Products Administration (NMPA) has released the “Medical Representative Management Measures (draft proposal)”,...
Chinese Pharmacopoeia Commission Approves Draft for ChP 2025 Edition
On December 27, the 12th Conference of the Chinese Pharmacopoeia Commission (ChPC) Executive Committee concluded...
NMPA and Local Governments Streamline Drug Approval Processes in China
The National Medical Products Administration (NMPA) has released a notification regarding the pilot work for...
CDE Includes Double-Crane’s Hydroxocobalamine and Sanofi Genzyme’s Fitusiran in Rare Disease Care Plan
China’s Center for Drug Evaluation (CDE) has announced the inclusion of China Resources Double-Crane Pharmaceutical...
NMPA’s CDE Issues Guidelines for Leveraging Real-World Data in Drug Regulation
The Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) has released...
NMPA Issues Interim Provisions for Overseas MAHs’ Designated Domestic Responsible Persons
The National Medical Products Administration (NMPA) has released the “Interim Provisions on the Management of...
NMPA Draft Proposal Aims to Strengthen Supervision of Drug Entrusted Manufacturing
The National Medical Products Administration (NMPA) has released a draft proposal titled “Announcement on Strengthening...
China’s NMPA Issues Guidelines for Domestic Manufacturing of Imported Medical Devices
The National Medical Products Administration (NMPA) has released a notification aimed at further clarifying the...
NMPA Releases 84th Batch of Reference Drugs for GQCE and First Batch Stripped of Status
The National Medical Products Administration (NMPA) has released the 84th batch of reference drugs for...
China’s NMPA and Denmark’s Medicines Agency Commit to Enhanced Regulatory Cooperation
The National Medical Products Administration (NMPA) of China and the Danish Medicines Agency have signed...
China’s NMPA Launches Pilot Program for Phased Manufacturing of Biological Products
The National Medical Products Administration (NMPA) has officially released the “Pilot Work Plan for Phased...
China’s NMPA Greenlights Pilot Plan for Phased Manufacturing of Biological Products
The National Medical Products Administration (NMPA) has given its stamp of approval to the “Pilot...